Cooley Receives Two Major Firmwide Life Sciences Awards

New York – September 8, 2023 –Cooley was named Corporate Firm of the Year and M&A Firm of the Year at the 11th annual LMG Life Sciences Americas Awards.

In addition to receiving the two firmwide awards, two of Cooley’s practice group leaders were also honored with prestigious individual awards. Barbara Borden, M&A partner and practice co-chair, was recognized as M&A Attorney of the Year, and Charlie Kim, capital markets partner, practice co-chair and Asian Pacific Islander Attorney Affinity Group co-chair, was named Corporate Attorney of the Year.

The firm also was noted for its successful client representations in two Impact Deals of the Year – its representation of Horizon Therapeutics in its $28 billion acquisition by Amgen and its representation of ACELYRIN, a late-stage clinical biopharma company, in its $621 million initial public offering, the second-largest biotechnology IPO and largest clinical-stage biotechnology IPO ever. Both deals were highlighted among the publication’s top deals since fall 2022.

This is the third consecutive year that Cooley has received at least one major award granted by LMG Life Sciences.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.